The most up-to-date SEER surveillance system for pancreatic cancer indicates that the 5 year survival rate is 6.0%. A physician at a local hospital has organized a trial that recruits 5,014 pancreatic cancer patients assesses the ability of his newly developed chemotherapy to improve that survival rate. By the end of 5 years of follow up, 376 patients of the original 5,014 were still alive. What is the 5 year survival rate for the therapy developed in the trial?